NET PROFIT (x1000 DKK)
EMPLOYEES
Biomedrex AB
Closing information (x1000 DKK)
Closing information | 2023/06 | 2022/06 | 2021/06 |
Turnover |
0
![]() |
0
![]() |
0 |
Financial expenses |
128
|
143
|
33 |
Earnings before taxes |
243
|
-578
|
-288 |
EBITDA |
367
|
-435
|
-255 |
Total assets |
10,086
|
10,374
|
4,962 |
Current assets |
126
|
747
|
611 |
Current liabilities |
2,379
|
2,199
|
731 |
Equity capital |
2,969
|
2,868
|
3,123 |
- share capital |
32
|
35
|
37 |
Employees (average) |
3
|
8
|
4 |
Financial ratios
Fiscal year | 2023/06 | 2022/06 | 2021/06 |
Solvency |
29.4%
|
27.6%
|
62.9% |
Turnover per employee |
0
![]() |
0
![]() |
0 |
Profit as a percentage of turnover | |||
Return on assets (ROA) |
3.7%
|
-4.2%
|
-5.1% |
Current ratio |
5.3%
|
34.0%
|
83.6% |
Return on equity (ROE) |
8.2%
|
-20.2%
|
-9.2% |
Change turnover |
0
![]() |
0
|
-377 |
Change turnover % | -100% | ||
Chg. No. of employees |
-5
|
4
|
3 |
Chg. No. of employees % |
-63%
|
100%
|
300% |
Total value of public sale
Fiscal year | 2023/06 | 2022/06 | 2021/06 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.